It’s time to shine a new light on narcolepsy. If you are among those who struggle with excessive daytime sleepiness, consider helping to advance our understanding of narcolepsy with cataplexy by joining the DynamicLight Study. Together, we can awaken new possibilities in the treatment of this disorder.
Narcolepsy with cataplexy can impose a significant burden on daily life. Researchers are working to identify treatment options that may have an impact on individuals with this disorder.
The DynamicLight Study is evaluating the safety and effectiveness of an investigational study drug that is being studied for narcolepsy with cataplexy. The entire study will last up to about 31 weeks. During this time, participants will be asked to attend up to 20 study visits.
For the first 16 weeks, all participants will receive the investigational study drug while also completing various study tests and procedures. The initial dose may be adjusted during the study treatment period. After the 16 weeks, participants will either continue taking the study drug or switch to a placebo (a substance that looks like the investigational study drug but does not contain any active ingredients) for up to 4 weeks.
You can play a role in helping researchers find more ways to study and treat narcolepsy with cataplexy by participating in this clinical research study.
Your Participation Matters
Research has shown that certain diseases and drugs may affect people differently based on several factors, including age, sex assigned at birth, race, and ethnic background. For this reason, it is important that people from all backgrounds be involved in medical research.
About the FirstLightStudy
The FirstLight Study is evaluating the safety and efficacy of an investigational study drug that is being studied for narcolepsy with cataplexy. Participants will receive the investigational study drug or a placebo (a substance that looks like the investigational study drug but does not contain any active ingredients) while also completing various study tests and procedures.
Neither participants nor the study staff will know if participants are receiving the investigational study drug or a placebo. Participants will attend about 10 scheduled study visits over the course of 14 to 23 weeks. The study duration will vary based on current narcolepsy medications (to be discontinued prior to beginning the study) and whether participants are enrolled in the long-term extension study.
You can play a role in helping researchers find more ways to study and treat narcolepsy with cataplexy by participating in this clinical research study.
Diversity Matters
Research has shown that certain diseases and drugs may affect people differently based on several factors, including age, sex assigned at birth, race, and ethnic background. For this reason, it is important that people from all backgrounds be involved in medical research.
